PanaKare Plus: Product Information

PANAKARE PLUS- pancrelipase lipase, pancrelipase amylase and pancrelipase protease tablet
Neogen Corporation-Mercer

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

PanaKare Plus Tablets

Pancreatic Enzyme Concentrate

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FOR ANIMAL USE ONLY

Each tablet contains a minimum of:

Lipase…………………………9,000 USP units

Protease…………………….57,000 USP units

Amylase……………………..64,000 USP units

Description:

PanaKare Plus is a pancreatic enzyme concentrate of porcine origin.

Precautions:

Discontinue use in animals with symptoms of sensitivity or allergy.

Made in the USA

KEEP OUT OF REACH OF CHILDREN

Indications:

As a digestive aid in replacement therapy where digestion of protein, carbohydrate and fat is inadequate due to exocrine pancreatic insufficiency.

Directions for use:

Dose is administered before each meal. Estimate dose according to the severity of the condition and weight of the animal.

Average dose/meal:

Dogs: 2-3 tablets

Cats: 1/2-1 tablet

Store tightly closed container in a dry place at temperatures not exceeding 35°C (95°F).

Lot No.:

Exp. Date:

Manufactured by: Neogen Corporation

Lexington, KY 40511 859-254-1221

animalsafety.neogen.com

PRINCIPAL DISPLAY PANEL — 500 Tablet Bottle

NDC: 59051-9067-7

PanaKare Plus Tablets

Pancreatic Enzyme Concentrate

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Net Contents: 500 Tablets

L1731-1218

Panakare Plus Tablets 500ct
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 100 Tablet Bottle

NDC: 59051-9067-5

PanaKare Plus Tablets

Pancreatic Enzyme Concentrate

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Net Contents: 100 Tablets

L1730-1218

Panakare Plus Tablets 100ct
(click image for full-size original)
PANAKARE PLUS
pancreatic enzyme tablet
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:59051-9067
Route of Administration Oral DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PANCRELIPASE LIPASE (PANCRELIPASE LIPASE) PANCRELIPASE LIPASE 9000 [iU]
PANCRELIPASE AMYLASE (PANCRELIPASE AMYLASE) PANCRELIPASE AMYLASE 64000 [iU]
PANCRELIPASE PROTEASE (PANCRELIPASE PROTEASE) PANCRELIPASE PROTEASE 57000 [iU]
Product Characteristics
Color brown Score no score
Shape ROUND Size 11mm
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:59051-9067-7 500 TABLET in 1 BOTTLE, PLASTIC None
2 NDC:59051-9067-5 100 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 05/15/2013
Labeler — Neogen Corporation-Mercer (042125879)
Establishment
Name Address ID/FEI Operations
Neogen Corporation-Mercer 042125879 analysis, label, manufacture

Revised: 05/2020 Neogen Corporation-Mercer

VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Our database mirrors the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VetLabel.com provides the full animal health subset of the FDA's repository. Veterinary information provided here is not intended as a substitute for direct consultation with a qualified veterinary professional.

Terms of Use | Copyright © 2020. All Rights Reserved.